(S)-N-ethyl-4-(7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy)butanamide

ID: ALA4584959

Chembl Id: CHEMBL4584959

PubChem CID: 155561753

Max Phase: Preclinical

Molecular Formula: C19H25N3O4

Molecular Weight: 359.43

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)CCCOc1cc2c(cc1OC)C(=O)N1CCC[C@H]1C=N2

Standard InChI:  InChI=1S/C19H25N3O4/c1-3-20-18(23)7-5-9-26-17-11-15-14(10-16(17)25-2)19(24)22-8-4-6-13(22)12-21-15/h10-13H,3-9H2,1-2H3,(H,20,23)/t13-/m0/s1

Standard InChI Key:  LGBXSZVUJTXNEJ-ZDUSSCGKSA-N

Alternative Forms

  1. Parent:

    ALA4584959

    ---

Associated Targets(Human)

JJN-3 (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1845AlogP: 2.31#Rotatable Bonds: 7
Polar Surface Area: 80.23Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.06CX LogP: 0.86CX LogD: 0.86
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.29

References

1. Corcoran DB, Lewis T, Nahar KS, Jamshidi S, Fegan C, Pepper C, Thurston DE, Rahman KM..  (2019)  Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs).,  62  (4): [PMID:30688457] [10.1021/acs.jmedchem.8b01849]

Source